|
| Ⅱstage clinical trail of Songling Xuemai Kang Capsule on treating hyperlipemia with hyperactivity of liver yang |
| Hits 1485 Download times 2253 Received:December 17, 2002 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2003.01.29 |
| Key Words
SXKC;hyperlipemia;hyperactivity of liver yang;clinical trial |
| Author Name | Affiliation | | Wang Baohe | The Second Affiliated Hospital to Tianjin University of Traditional Chinese Medicine, Tianjin 300150, China | | Zhang Guangming | 河北省张家口市宣化区中医院, 张家口, 075100 |
|
| Abstract
|
| [Objective] To observe the clinical effect and safety of Songling Xuemai Kang Capsule (SXKC) on treating hyperlipemia with hyperactivity of liver yang.[Methods] A double blind, double model and positive drugs controlled method was used.[Results] SXKC had an obvious effect on lowing blood-lipid, especially triglyceride and cholestrol and TC-HDL-C/HDL-C. There was a marked difference between before and after treatment. It had an equal effect to that of Gynostemma Pentaphyllum Saponin Capsule, a known positive drug. It could also improve headache, vertigo, restlessness, palpitation and insomnia with no side effect.[Conclusion] SXKC can lower blood-lipid and improve clinical symptoms with no toxic and side effect. |
|
